Why do cancers have high aerobic glycolysis? - PubMed (original) (raw)
Review
doi: 10.1038/nrc1478.
Affiliations
- PMID: 15516961
- DOI: 10.1038/nrc1478
Review
Why do cancers have high aerobic glycolysis?
Robert A Gatenby et al. Nat Rev Cancer. 2004 Nov.
Abstract
If carcinogenesis occurs by somatic evolution, then common components of the cancer phenotype result from active selection and must, therefore, confer a significant growth advantage. A near-universal property of primary and metastatic cancers is upregulation of glycolysis, resulting in increased glucose consumption, which can be observed with clinical tumour imaging. We propose that persistent metabolism of glucose to lactate even in aerobic conditions is an adaptation to intermittent hypoxia in pre-malignant lesions. However, upregulation of glycolysis leads to microenvironmental acidosis requiring evolution to phenotypes resistant to acid-induced cell toxicity. Subsequent cell populations with upregulated glycolysis and acid resistance have a powerful growth advantage, which promotes unconstrained proliferation and invasion.
Similar articles
- Metabolic changes during carcinogenesis: potential impact on invasiveness.
Smallbone K, Gatenby RA, Gillies RJ, Maini PK, Gavaghan DJ. Smallbone K, et al. J Theor Biol. 2007 Feb 21;244(4):703-13. doi: 10.1016/j.jtbi.2006.09.010. Epub 2006 Sep 16. J Theor Biol. 2007. PMID: 17055536 - The glycolytic phenotype in carcinogenesis and tumor invasion: insights through mathematical models.
Gatenby RA, Gawlinski ET. Gatenby RA, et al. Cancer Res. 2003 Jul 15;63(14):3847-54. Cancer Res. 2003. PMID: 12873971 - Hypoxia and adaptive landscapes in the evolution of carcinogenesis.
Gillies RJ, Gatenby RA. Gillies RJ, et al. Cancer Metastasis Rev. 2007 Jun;26(2):311-7. doi: 10.1007/s10555-007-9065-z. Cancer Metastasis Rev. 2007. PMID: 17404691 Review. - Metabolism and its sequelae in cancer evolution and therapy.
Gillies RJ, Gatenby RA. Gillies RJ, et al. Cancer J. 2015 Mar-Apr;21(2):88-96. doi: 10.1097/PPO.0000000000000102. Cancer J. 2015. PMID: 25815848 Free PMC article. Review.
Cited by
- Cancer-generated lactic acid: a regulatory, immunosuppressive metabolite?
Choi SY, Collins CC, Gout PW, Wang Y. Choi SY, et al. J Pathol. 2013 Aug;230(4):350-5. doi: 10.1002/path.4218. J Pathol. 2013. PMID: 23729358 Free PMC article. Review. - Long Non-Coding RNAs in Drug Resistance of Gastric Cancer: Complex Mechanisms and Potential Clinical Applications.
Meng X, Bai X, Ke A, Li K, Lei Y, Ding S, Dai D. Meng X, et al. Biomolecules. 2024 May 22;14(6):608. doi: 10.3390/biom14060608. Biomolecules. 2024. PMID: 38927012 Free PMC article. Review. - The Expression of Glut-1, CAIX, and MCT4 in Mucinous Carcinoma.
Kim S, Jung WH, Koo JS. Kim S, et al. J Breast Cancer. 2013 Jun;16(2):146-51. doi: 10.4048/jbc.2013.16.2.146. Epub 2013 Jun 28. J Breast Cancer. 2013. PMID: 23843845 Free PMC article. - Metabolomic Markers of Colorectal Tumor With Different Clinicopathological Features.
Long Z, Zhou J, Xie K, Wu Z, Yin H, Daria V, Tian J, Zhang N, Li L, Zhao Y, Wang F, Wang M, Cui Y. Long Z, et al. Front Oncol. 2020 Jun 17;10:981. doi: 10.3389/fonc.2020.00981. eCollection 2020. Front Oncol. 2020. PMID: 32626659 Free PMC article. - Profiling of plasma metabolites in canine oral melanoma using gas chromatography-mass spectrometry.
Kawabe M, Baba Y, Tamai R, Yamamoto R, Komori M, Mori T, Takenaka S. Kawabe M, et al. J Vet Med Sci. 2015 Aug;77(8):1025-8. doi: 10.1292/jvms.14-0641. Epub 2015 May 4. J Vet Med Sci. 2015. PMID: 25843037 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases